Welcome to the E-Lab!
row, left to right: Jarvis, Nathan, Bogdan, Dr.
Eagon, Aashrita. Front row, left to right:
Brandon, Tyler, Kasey, Dr. Liyanage. Not
pictured: Natalie & Jordan)
Our research group focuses on the
development of small molecule pharmaceuticals targeting a
variety of diseases, particularly malaria and cancer.
Students are involved in all aspects of drug synthesis and
pre-clinical development. Our group is also interested
in developing new synthetic methods to produce compounds
quickly & with minimal purification in an effort to
reduce development costs. Students majoring in
Chemistry, Biochemistry, or related majors are welcome to
join, but two quarters of organic chemistry lab are
required to join due to the complexity of the
chemistry involved. Students minoring in
computer science are also welcome to contribute to our
in silico drug screening program. Current
projects include the development of kinase-based
chemotherapy agents, anti-malarials with novel modes of
action targeting multi-drug resistant strains of Plasmodium
falciparum, synthetic opioids with minimized addiction
profiles, and in silico screening programs to
discover new drug candidates for infectious diseases.